| 000 | 03541nam a22003735i 4500 | ||
|---|---|---|---|
| 001 | 80523 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040309.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 131203s2014 gw | s |||| 0|eng d | ||
| 020 | _a9783642400346 | ||
| 024 | 7 |
_a10.1007/978-3-642-40034-6 _2doi |
|
| 050 | 4 |
_aRE501 _b.D574 2014 |
|
| 245 | 1 | 0 |
_aDiseases of the Vitreo-Macular Interface _cedited by Aniz Girach, Marc D. Smet. |
| 260 |
_aBerlin, Heidelberg _bSpringer _c2014 |
||
| 300 |
_a1 recurso en línea (IX, 122 páginas) _b40 ilustraciones, 20 ilustraciones en color |
||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 490 | 0 |
_aEssentials in Ophthalmology _x1612-3212 |
|
| 505 | 0 | _aIntroduction: Unmet Medical Need -- Epidemiology of Vitreo-Macular Interface Diseases -- Anatomy and Physiology of the Vitreo-Macular Interface -- Pathophysiology of the Ageing Vitreous -- Pathophysiology of Vitreo-Macular Traction -- Imaging of the Vitreo-Macular Interface -- Clinical Manifestations of Vitreo-Macular Interface Disease -- Vitreo-Macular Traction and Age-Related Macular Degeneration -- Treatment Paradigm for Vitreo-Macular Interface Diseases -- Pharmacologic Vitreolysis - Experimental Evidence -- Pharmacologic Vitreolysis - Clinical Trial Data -- Pharmacologic Vitreolysis - New Perspectives, Future Directions. | |
| 520 | 3 | _aDisease of the vitreo-macular interface is characterized by vitreo-macular adhesion (VMA), which can lead to abnormal forces on the retina termed vitreo-macular traction (VMT). This combination of VMA and VMT can itself cause impairment of vision and is implicated in a variety of disorders, including wet age-related macular degeneration, diabetic retinopathy, macular edema, and macular hole. Vitreo-macular interface disease has recently begun to receive more attention owing in part to the advent of new imaging techniques that allow more accurate diagnosis and in part to advances in treatment.This clinically oriented book is the first to be devoted wholly to the diagnosis and treatment of vitreo-macular interface disease. World-renowned experts in the field discuss epidemiologic, anatomic, and physiologic aspects, document the findings obtained with newer imaging techniques, such as spectral domain optical coherence tomography, describe the treatment options, and report on the results of preclinical and clinical trials, including some previously unpublished findings. This book will prove invaluable for ophthalmologists as we advance toward a future in which treatments of diseases such as age-related macular degeneration and diabetic retinopathy will likely require adjunctive therapy to tackle VMA/VMT concurrently. | |
| 710 | 2 |
_aSpringerLink (Online service) _0Local _9106996 |
|
| 942 |
_2lcc _cLE |
||
| 988 | _aEBOOK, asignarmaterias, EBSPRINGER, | ||
| 650 | 7 |
_aOftalmología _0 _2embne _9139186 |
|
| 650 | 2 | 7 |
_aOftalmología _0 _2embne _9139186 |
| 700 | 1 |
_aGirach, Aniz _eeditor literario _988780 _0Local |
|
| 700 | 1 |
_aSmet, Marc D _eeditor literario _988781 _0Local |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-642-40034-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 907 |
_a.b12882768 _b10-10-17 _c11-11-15 |
||
| 998 |
_am _a_alco _a_vill _b11-11-15 _cm _dz _e- _feng _ggw _h0 |
||
| 945 |
_aRE501 .D574 2014 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11562584 _z06-04-17 |
||
| 999 |
_c80523 _d80523 _x1 |
||